Patients in the T2DKD, T2DNRF and CCKD groups were prescribed medications such as angiotensin converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBs), statins, oral hypoglycaemic drugs and/or insulin to manage hypertension, dyslipidaemia and diabetes respectively. The gene discussed is INS; the disease is diabetes mellitus.